In-Vivo Toxicology Market Trend, Share, Growth, Size and Forecast 2028

Creator: Zion Market Research
License: https://www.zionmarketresearch.com/privacy-policy

In-Vivo Toxicology Market By Product Types(Instruments, Animal Models, and Reagents & Kits), By Testing Types (Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-acute Toxicity Testing, and Acute Toxicity Testing), By Toxicity Endpoints (Immunotoxicity, Systemic), By Testing Facility (Outsourced, In-House), By End-User (Academic Institutes, Research Institutes, and CRO’s) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022-2028-

Category: Pharmaceutical Report Format : PDF Pages: 222 Report Code: ZMR-965 Published Date: Jun-2022 Status : Published

Global in-vivo toxicology market size grasped a revenue growth of $5.23 billion in 2021 and is projected to around $7.54 B by 2028 at a CAGR rate of 6.3%

Table Of Content

Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
  - 1.3.1 Market Research Type
  - 1.3.2 Market research methodology
Chapter 2. Executive Summary
- 2.1 Global In-Vivo Toxicology Market, (2022 - 2028) (USD Billion)
- 2.2 Global In-Vivo Toxicology Market : snapshot
Chapter 3. Global In-Vivo Toxicology Market - Industry Analysis
- 3.1 In-Vivo Toxicology Market: Market Dynamics
- 3.2 Market Drivers
  - 3.2.1 Recent innovations in pharmaceutical and biotechnology industries along with rising focus on personalized medications to propel the market growth
- 3.3 Market Restraints
  - 3.3.1. Availability of alternate methods of testing to animal testing and growing contempt against animal testing hampers the market growth
- 3.4 Market Opportunities
  - 3.4.1. The increasing trend of humanized animal model testing in preclinical research provides a lucrative opportunity for market growth
- 3.5 Market Challenges
  - 3.5.1. Government regulations against harming animals for medical testing pose a challenge for the market growth
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
  - 3.7.1 Market attractiveness analysis By Product Type
  - 3.7.2 Market attractiveness analysis By Testing Types
  - 3.7.3 Market attractiveness analysis By Toxicity Endpoints
  - 3.7.4 Market attractiveness analysis By Testing facility
  - 3.7.5 Market attractiveness analysis By End-user
Chapter 4. Global In-Vivo Toxicology Market- Competitive Landscape
- 4.1 Company market share analysis
  - 4.1.1 Global In-Vivo Toxicology Market: company market share, 2021
- 4.2 Strategic development
  - 4.2.1 Acquisitions & mergers
  - 4.2.2 New Product launches
  - 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
  - 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
Chapter 5. Global In-Vivo Toxicology Market - Product Type Analysis
- 5.1 Global In-Vivo Toxicology Market overview: By Product Type
  - 5.1.1 Global In-Vivo Toxicology Market share, By Product Type, 2021 and 2028
- 5.2 Instruments
  - 5.2.1 Global In-Vivo Toxicology Market by Instruments, 2022 - 2028 (USD Billion)
- 5.3 Animal Models
  - 5.3.1 Global In-Vivo Toxicology Market by Animal Models, 2022 - 2028 (USD Billion)
- 5.4 Reagents & Kits
  - 5.4.1 Global In-Vivo Toxicology Market by Reagents & Kits, 2022 - 2028 (USD Billion)
Chapter 6. Global In-Vivo Toxicology Market - Testing Types Analysis
- 6.1 Global In-Vivo Toxicology Market overview: By Testing Types
  - 6.1.1 Global In-Vivo Toxicology Market share, By Testing Types, 2021 and 2028
- 6.2 Chronic Toxicity Testing
  - 6.2.1 Global In-Vivo Toxicology Market by Chronic Toxicity Testing, 2022 - 2028 (USD Billion)
- 6.3 Sub-Chronic Toxicity Testing
  - 6.3.1 Global In-Vivo Toxicology Market by Sub-Chronic Toxicity Testing, 2022 - 2028 (USD Billion)
- 6.4 Sub-acute Toxicity Testing
  - 6.4.1 Global In-Vivo Toxicology Market by Sub-acute Toxicity Testing, 2022 - 2028 (USD Billion)
- 6.5 Acute Toxicity Testing
  - 6.5.1 Global In-Vivo Toxicology Market by Acute Toxicity Testing, 2022 - 2028 (USD Billion)
Chapter 7. Global In-Vivo Toxicology Market - Toxicity Endpoints Analysis
- 7.1 Global In-Vivo Toxicology Market overview: By Toxicity Endpoints
  - 7.1.1 Global In-Vivo Toxicology Market share, By Toxicity Endpoints, 2021 and 2028
- 7.2 Immunotoxicity
  - 7.2.1 Global In-Vivo Toxicology Market by Immunotoxicity, 2022 - 2028 (USD Billion)
- 7.3 Systemic
  - 7.3.1 Global In-Vivo Toxicology Market by Systemic, 2022 - 2028 (USD Billion)
Chapter 8. Global In-Vivo Toxicology Market - Testing facility Analysis
- 8.1 Global In-Vivo Toxicology Market overview: By Testing facility
  - 8.1.1 Global In-Vivo Toxicology Market share, By Testing facility, 2021 and 2028
- 8.2 Outsourced
  - 8.2.1 Global In-Vivo Toxicology Market by Outsourced, 2022 - 2028 (USD Billion)
- 8.3 In-house
  - 8.3.1 Global In-Vivo Toxicology Market by In-house, 2022 - 2028 (USD Billion)
Chapter 9. Global In-Vivo Toxicology Market - End-user Analysis
- 9.1 Global In-Vivo Toxicology Market overview: By End-user
  - 9.1.1 Global In-Vivo Toxicology Market share, By End-user, 2021 and 2028
- 9.2 Academic Institutes
  - 9.2.1 Global In-Vivo Toxicology Market by Academic Institutes, 2022 - 2028 (USD Billion)
- 9.3 Research Institutes
  - 9.3.1 Global In-Vivo Toxicology Market by Research Institutes, 2022 - 2028 (USD Billion)
- 9.4 CRO’s
  - 9.4.1 Global In-Vivo Toxicology Market by CRO’s, 2022 - 2028 (USD Billion)
Chapter 10. In-Vivo Toxicology Market - Regional Analysis
- 10.1 Global In-Vivo Toxicology Market Regional Overview
- 10.2 Global In-Vivo Toxicology Market Share, by Region, 2021 & 2028 (USD Billion)
- 10.3. North America
  - 10.3.1 North America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
    - 10.3.1.1 North America In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
- 10.4 North America In-Vivo Toxicology Market, by Product Type, 2022 - 2028
  - 10.4.1 North America In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
- 10.5 North America In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
  - 10.5.1 North America In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
- 10.6 North America In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
  - 10.6.1 North America In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 10.7 North America In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
  - 10.7.1 North America In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
- 10.8 North America In-Vivo Toxicology Market, by End-user, 2022 - 2028
  - 10.8.1 North America In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
- 10.4. Europe
  - 10.4.2 Europe In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
    - 10.4.2.1 Europe In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
- 10.4 Europe In-Vivo Toxicology Market, by Product Type, 2022 - 2028
  - 10.4.1 Europe In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
- 10.5 Europe In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
  - 10.5.1 Europe In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
- 10.6 Europe In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
  - 10.6.1 Europe In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 10.7 Europe In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
  - 10.7.1 Europe In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
- 10.8 Europe In-Vivo Toxicology Market, by End-user, 2022 - 2028
  - 10.8.1 Europe In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
- 10.5. Asia Pacific
  - 10.5.3 Asia Pacific In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
    - 10.5.3.1 Asia Pacific In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
- 10.4 Asia Pacific In-Vivo Toxicology Market, by Product Type, 2022 - 2028
  - 10.4.1 Asia Pacific In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
- 10.5 Asia Pacific In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
  - 10.5.1 Asia Pacific In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
- 10.6 Asia Pacific In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
  - 10.6.1 Asia Pacific In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 10.7 Asia Pacific In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
  - 10.7.1 Asia Pacific In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
- 10.8 Asia Pacific In-Vivo Toxicology Market, by End-user, 2022 - 2028
  - 10.8.1 Asia Pacific In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
- 10.6. Latin America
  - 10.6.4 Latin America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
    - 10.6.4.1 Latin America In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
- 10.4 Latin America In-Vivo Toxicology Market, by Product Type, 2022 - 2028
  - 10.4.1 Latin America In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
- 10.5 Latin America In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
  - 10.5.1 Latin America In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
- 10.6 Latin America In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
  - 10.6.1 Latin America In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 10.7 Latin America In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
  - 10.7.1 Latin America In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
- 10.8 Latin America In-Vivo Toxicology Market, by End-user, 2022 - 2028
  - 10.8.1 Latin America In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
- 10.7. The Middle-East and Africa
  - 10.7.5 The Middle-East and Africa In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
    - 10.7.5.1 The Middle-East and Africa In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
- 10.4 The Middle-East and Africa In-Vivo Toxicology Market, by Product Type, 2022 - 2028
  - 10.4.1 The Middle-East and Africa In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
- 10.5 The Middle-East and Africa In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
  - 10.5.1 The Middle-East and Africa In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
- 10.6 The Middle-East and Africa In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
  - 10.6.1 The Middle-East and Africa In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 10.7 The Middle-East and Africa In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
  - 10.7.1 The Middle-East and Africa In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
- 10.8 The Middle-East and Africa In-Vivo Toxicology Market, by End-user, 2022 - 2028
  - 10.8.1 The Middle-East and Africa In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
Chapter 11. Company Profiles
- 11.1 Charles River Laboratories
  - 11.1.1 Overview
  - 11.1.2 Financials
  - 11.1.3 Product Portfolio
  - 11.1.4 Business Strategy
  - 11.1.5 Recent Developments
- 11.2 The Jackson Laboratory
  - 11.2.1 Overview
  - 11.2.2 Financials
  - 11.2.3 Product Portfolio
  - 11.2.4 Business Strategy
  - 11.2.5 Recent Developments
- 11.3 Envigo
  - 11.3.1 Overview
  - 11.3.2 Financials
  - 11.3.3 Product Portfolio
  - 11.3.4 Business Strategy
  - 11.3.5 Recent Developments
- 11.4 Taconic Biosciences
  - 11.4.1 Overview
  - 11.4.2 Financials
  - 11.4.3 Product Portfolio
  - 11.4.4 Business Strategy
  - 11.4.5 Recent Developments
- 11.5 Janvier Labs
  - 11.5.1 Overview
  - 11.5.2 Financials
  - 11.5.3 Product Portfolio
  - 11.5.4 Business Strategy
  - 11.5.5 Recent Developments
- 11.6 Thermo Fisher Scientific
  - 11.6.1 Overview
  - 11.6.2 Financials
  - 11.6.3 Product Portfolio
  - 11.6.4 Business Strategy
  - 11.6.5 Recent Developments
- 11.7 Danaher Corporation
  - 11.7.1 Overview
  - 11.7.2 Financials
  - 11.7.3 Product Portfolio
  - 11.7.4 Business Strategy
  - 11.7.5 Recent Developments
- 11.8 Waters Corporation
  - 11.8.1 Overview
  - 11.8.2 Financials
  - 11.8.3 Product Portfolio
  - 11.8.4 Business Strategy
  - 11.8.5 Recent Developments
- 11.9 Agilent Technologies
  - 11.9.1 Overview
  - 11.9.2 Financials
  - 11.9.3 Product Portfolio
  - 11.9.4 Business Strategy
  - 11.9.5 Recent Developments
- 11.10 Shimadzu Corporation
  - 11.10.1 Overview
  - 11.10.2 Financials
  - 11.10.3 Product Portfolio
  - 11.10.4 Business Strategy
  - 11.10.5 Recent Developments
- 11.11 Bruker Corporation
  - 11.11.1 Overview
  - 11.11.2 Financials
  - 11.11.3 Product Portfolio
  - 11.11.4 Business Strategy
  - 11.11.5 Recent Developments
- 11.12 PerkinElmer
  - 11.12.1 Overview
  - 11.12.2 Financials
  - 11.12.3 Product Portfolio
  - 11.12.4 Business Strategy
  - 11.12.5 Recent Developments
- 11.13 MerckkgaA
  - 11.13.1 Overview
  - 11.13.2 Financials
  - 11.13.3 Product Portfolio
  - 11.13.4 Business Strategy
  - 11.13.5 Recent Developments
- 11.14 GE Healthcare
  - 11.14.1 Overview
  - 11.14.2 Financials
  - 11.14.3 Product Portfolio
  - 11.14.4 Business Strategy
  - 11.14.5 Recent Developments
- 11.15 Bio-Rad laboratories
  - 11.15.1 Overview
  - 11.15.2 Financials
  - 11.15.3 Product Portfolio
  - 11.15.4 Business Strategy
  - 11.15.5 Recent Developments
- 11.16 genOway
  - 11.16.1 Overview
  - 11.16.2 Financials
  - 11.16.3 Product Portfolio
  - 11.16.4 Business Strategy
  - 11.16.5 Recent Developments
- 11.17 Cyagen Biosciences
  - 11.17.1 Overview
  - 11.17.2 Financials
  - 11.17.3 Product Portfolio
  - 11.17.4 Business Strategy
  - 11.17.5 Recent Developments
- 11.18 GVK BIO
  - 11.18.1 Overview
  - 11.18.2 Financials
  - 11.18.3 Product Portfolio
  - 11.18.4 Business Strategy
  - 11.18.5 Recent Developments
- 11.19 Polygene
  - 11.19.1 Overview
  - 11.19.2 Financials
  - 11.19.3 Product Portfolio
  - 11.19.4 Business Strategy
  - 11.19.5 Recent Developments
- 11.20 Crown Biosciences
  - 11.20.1 Overview
  - 11.20.2 Financials
  - 11.20.3 Product Portfolio
  - 11.20.4 Business Strategy
  - 11.20.5 Recent Developments
- 11.21 Transcure Bioservices
  - 11.21.1 Overview
  - 11.21.2 Financials
  - 11.21.3 Product Portfolio
  - 11.21.4 Business Strategy
  - 11.21.5 Recent Developments
- 11.22 Harbour BioMed.
  - 11.22.1 Overview
  - 11.22.2 Financials
  - 11.22.3 Product Portfolio
  - 11.22.4 Business Strategy
  - 11.22.5 Recent Developments

Table Of Figures

1. Market research Type
2. Market research methodology
3. Global In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global In-Vivo Toxicology Market attractiveness, By Product Type
6. Global In-Vivo Toxicology Market attractiveness, By Testing Types
7. Global In-Vivo Toxicology Market attractiveness, By Toxicity Endpoints
8. Global In-Vivo Toxicology Market attractiveness, By Testing facility
9. Global In-Vivo Toxicology Market attractiveness, By End-user
10. Global In-Vivo Toxicology Market share by Product Type, 2022 and 2028 (USD Billion)
11. Global In-Vivo Toxicology Market by Instruments, 2022 - 2028 (USD Billion)
12. Global In-Vivo Toxicology Market by Animal Models, 2022 - 2028 (USD Billion)
13. Global In-Vivo Toxicology Market by Reagents & Kits, 2022 - 2028 (USD Billion)
14. Global In-Vivo Toxicology Market share by Testing Types, 2022 and 2028 (USD Billion)
15. Global In-Vivo Toxicology Market by Chronic Toxicity Testing, 2022 - 2028 (USD Billion)
16. Global In-Vivo Toxicology Market by Sub-Chronic Toxicity Testing, 2022 - 2028 (USD Billion)
17. Global In-Vivo Toxicology Market by Sub-acute Toxicity Testing, 2022 - 2028 (USD Billion)
18. Global In-Vivo Toxicology Market by Acute Toxicity Testing, 2022 - 2028 (USD Billion)
19. Global In-Vivo Toxicology Market share by Toxicity Endpoints, 2022 and 2028 (USD Billion)
20. Global In-Vivo Toxicology Market by Immunotoxicity, 2022 - 2028 (USD Billion)
21. Global In-Vivo Toxicology Market by Systemic, 2022 - 2028 (USD Billion)
22. Global In-Vivo Toxicology Market share by Testing facility, 2022 and 2028 (USD Billion)
23. Global In-Vivo Toxicology Market by Outsourced, 2022 - 2028 (USD Billion)
24. Global In-Vivo Toxicology Market by In-house, 2022 - 2028 (USD Billion)
25. Global In-Vivo Toxicology Market share by End-user, 2022 and 2028 (USD Billion)
26. Global In-Vivo Toxicology Market by Academic Institutes, 2022 - 2028 (USD Billion)
27. Global In-Vivo Toxicology Market by Research Institutes, 2022 - 2028 (USD Billion)
28. Global In-Vivo Toxicology Market by CRO’s, 2022 - 2028 (USD Billion)
29. Global In-Vivo Toxicology Market share, by Region, 2022 and 2028
30. North America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
31. Europe In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
32. Asia Pacific In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
33. Latin America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
34. The Middle-East and Africa In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)

Table Of Tables

1. Global In-Vivo Toxicology Market: Snapshot
2. Drivers of the In-Vivo Toxicology Market: impact analysis
3. North America In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
4. North America In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
5. North America In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
6. North America In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
7. North America In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
8. U.S. In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
9. U.S. In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
10. U.S. In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
11. U.S. In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
12. U.S. In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
13. Canada In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
14. Canada In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
15. Canada In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
16. Canada In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
17. Canada In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
18. Europe In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
19. Europe In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
20. Europe In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
21. Europe In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
22. Europe In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
23. Germany In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
24. Germany In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
25. Germany In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
26. Germany In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
27. Germany In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
28. France In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
29. France In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
30. France In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
31. France In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
32. France In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
33. U.K. In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
34. U.K. In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
35. U.K. In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
36. U.K. In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
37. U.K. In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
38. Italy In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
39. Italy In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
40. Italy In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
41. Italy In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
42. Italy In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
43. Spain In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
44. Spain In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
45. Spain In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
46. Spain In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
47. Spain In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
48. Rest of Europe In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
49. Rest of Europe In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
50. Rest of Europe In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
51. Rest of Europe In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
52. Rest of Europe In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
53. Asia Pacific In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
54. Asia Pacific In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
55. Asia Pacific In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
56. Asia Pacific In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
57. Asia Pacific In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
58. China In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
59. China In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
60. China In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
61. China In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
62. China In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
63. Japan In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
64. Japan In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
65. Japan In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
66. Japan In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
67. Japan In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
68. India In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
69. India In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
70. India In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
71. India In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
72. India In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
73. South Korea In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
74. South Korea In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
75. South Korea In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
76. South Korea In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
77. South Korea In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
78. South-East Asia In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
79. South-East Asia In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
80. South-East Asia In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
81. South-East Asia In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
82. South-East Asia In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
83. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
84. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
85. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
86. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
87. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
88. Latin America In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
89. Latin America In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
90. Latin America In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
91. Latin America In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
92. Latin America In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
93. Brazil In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
94. Brazil In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
95. Brazil In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
96. Brazil In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
97. Brazil In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
98. Mexico In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
99. Mexico In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
100. Mexico In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
101. Mexico In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
102. Mexico In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
103. Rest of Latin America In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
104. Rest of Latin America In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
105. Rest of Latin America In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
106. Rest of Latin America In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
107. Rest of Latin America In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
108. The Middle-East and Africa In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
109. The Middle-East and Africa In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
110. The Middle-East and Africa In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
111. The Middle-East and Africa In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
112. The Middle-East and Africa In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
113. GCC Countries In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
114. GCC Countries In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
115. GCC Countries In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
116. GCC Countries In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
117. GCC Countries In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
118. South Africa In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
119. South Africa In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
120. South Africa In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
121. South Africa In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
122. South Africa In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
123. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
124. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
125. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
126. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
127. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)

Methodology

FrequentlyAsked Questions

Which Key factors will influence in-vivo toxicology market growth over 2022-2028?

Recent innovations in pharmaceutical and biotechnology industries along with a rising focus on personalized medications propel market growth

What will be the value of the in-vivo toxicology market during 2022 – 2028?

According to the report by Zion Market Research, The global In-Vivo toxicology market was worth around $ 5.23 billion in 2021 and is predicted to grow to around $ 7.54 billion by 2028 at a CAGR rate of 6.3% over the forecast period

Which region will contribute notably towards the in-vivo toxicology market value?

North America is the largest share of the in-vivo toxicology market. This is due to the presence of major players in the in-vivo toxicology market. There is a growing trend of biomedical research and preclinical activities by CROs happening in this region which makes it the most dominating region for the in-vivo toxicology market.

What are the major players leveraging the in-vivo toxicology market growth?

The key players in the global in-vivo toxicology market are Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Janvier Labs, Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, Agilent Technologies, Shimadzu Corporation, Bruker Corporation, PerkinElmer, MerckkgaA, GE Healthcare, Bio-Rad laboratories, genOway, Cyagen Biosciences, GVK BIO, Polygene, Crown Biosciences, Transcure Bioservices, and Harbour BioMed.

Choose License Type

Single User License $4199.00 Multi User License $5199.00 Enterprise Access License $7199.00

Request Free Brochure

Ask for Customization

Free Analysis

Inquiry For Buying

List of Contents

Industry Prospective:Overview Growth Drivers Covid-19 Impact Restraints Opportunities Challenges Report Scope Segmentation Recent Developments:Regional Landscape:Competitive Landscape:Report Scope:Global in-vivo toxicology market segmentation follows

RelatedNews

HappyClients

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We have secured system to process your transaction.

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed

In-Vivo Toxicology Market Trend, Share, Growth, Size and Forecast 2028

Table Of Content

Table Of Figures

Table Of Tables

Methodology

Which Key factors will influence in-vivo toxicology market growth over 2022-2028?

What will be the value of the in-vivo toxicology market during 2022 – 2028?

Which region will contribute notably towards the in-vivo toxicology market value?

What are the major players leveraging the in-vivo toxicology market growth?

Choose License Type

List of Contents

How to Order

Disclaimer

FAQs

Return Policy

Sitemap

About Us

Terms and Conditions

Contact Us

Privacy Policy

ZMR in News

Career